SuperworthOutlook Therapeutics shares outstanding OTLK
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 136.7M
- On a year earlier
- +270.0%
- more shares
Outlook Therapeutics had 136.7M diluted shares outstanding on average in Q3 FY26, the quarter to Jun 30, 2026.
That is 270.0% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 47.1M | +99% |
| FY2024 | 23.7M | +82% |
| FY2023 | 13M | +18% |
| FY2022 | 11M | +30% |
| FY2021 | 8.5M | +40% |
| FY2020 | 6.1M | +330% |
| FY2019 | 1.4M | +214% |
| FY2018 | 451.3K | +192% |
| FY2017 | 154.5K | +8% |
| FY2016 | 142.5K | +114% |
| FY2015 | 66.6K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY26 | 136.7M | +270% | |
| Q2 FY26 | 81.8M | +165% | |
| Q1 FY26 | 60.2M | +148% | |
| Q4 FY25 | 47.1M | +99% | |
| Q3 FY25 | 37M | +45% | |
| Q2 FY25 | 30.9M | +116% | |
| Q1 FY25 | 24.2M | +86% | |
| Q4 FY24 | 23.7M | +82% | |
| Q3 FY24 | 25.5M | +98% | |
| Q2 FY24 | 14.3M | +11% | |
| Q1 FY24 | 13M | +14% | |
| Q4 FY23 | 13M | +18% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Outlook Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.